What is Access Genetics?
Access Genetics, operating in tandem with OralDNA Labs, functions as a premier national reference laboratory specializing in advanced molecular diagnostics. The company distinguishes itself through a dual-focus approach: maintaining a robust foundation in traditional blood chemistry while pioneering innovative salivary diagnostic platforms. By integrating sophisticated DNA testing methodologies, the firm provides clinicians and patients with actionable health data, effectively bridging the gap between complex laboratory science and accessible diagnostic services. Their market authority is built upon a long-standing commitment to technical accuracy and superior customer service, positioning them as a vital infrastructure provider in the personalized diagnostics ecosystem.
How much funding has Access Genetics raised?
Access Genetics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Access Genetics
PPP
Public-Private Partnership
What's next for Access Genetics?
With the successful acquisition of this latest capital, Access Genetics is expected to prioritize the scaling of its proprietary salivary diagnostic technologies. Strategic initiatives will likely include the expansion of laboratory capacity to accommodate higher throughput and the potential integration of automated data analytics to streamline diagnostic reporting. As the company navigates this late-stage growth phase, the focus will shift toward deepening its penetration in the clinical diagnostics market and potentially exploring new therapeutic areas where molecular insights can drive improved patient outcomes. The firm remains poised to capitalize on the broader industry shift toward decentralized and non-invasive testing solutions, ensuring long-term competitive relevance in the evolving healthcare landscape.
See full Access Genetics company page
